Top Markets
#1 Nesa Nesa +337.53%
#2 EXOD EXOD +22.78%
#3 MetaDAO MetaDAO +17.01%
#4 Status Status +12.64%
#5 Wrapped NXM Wrapped NXM +7.23%
#6 Kinesis Silver Kinesis Silver +6.60%
#7 Venom Venom +5.81%
#8 Tornado Cash Tornado Cash +4.89%
#9 HOME HOME +4.80%
#10 Ontology Gas Ontology Gas +3.99%
Coin of the day
Nesa Nesa
Settings
Language
ENGLISH
Currency
USD
Theme
Cannara Biotech Inc. Cannara Biotech Inc.

Cannara Biotech Inc.

LOVE
Rank in Stocks #19980
Cannara Biotech Inc., alongside its affiliated entities, specializes in the... Cannara Biotech Inc., alongside its affiliated entities, specializes in the indoor cultivation, processing, and distribution of cannabis and related products across Canada. The company operates with a dual business model, encompassing both cannabis operations and real estate activities. Its diverse product portfolio is marketed under distinct brand names such as TRIBAL, nugz, and ORCHID CBD. Distribution is managed through both wholesale channels and online retail platforms. Established in 2017, Cannara Biotech Inc. maintains its headquarters in Saint-Laurent, Canada.
Share Price
$1.47
Last synced: 2026-08-25
Market Cap
$145.00M
Change (1 day)
0.00%
Change (1 year)
10.97%
Country
CA
Trade Cannara Biotech Inc. (LOVE)

Category

Healthcare
Revenue for Cannara Biotech Inc. (LOVE)
Revenue in Aug 2026 TTM: 0
According to Cannara Biotech Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Cannara Biotech Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN